CAS RN: 1422371-27-4
(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin
Product Availability
Choose a grade to view its available package options.
3 package records 3 with current stock 1 grade group
Grade
97% (3)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20260407
100mg
In stock
Shanghai Inquiry
Batchno.20250121
1g
In stock
Shanghai Inquiry
Batchno.20250915
250mg
In stock
Shanghai, Shenzhen Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: >98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1422371-27-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
>98%
0
Out of Stock
Beijing
Inquiry
1422371-27-4 / (3aS,8aS)-4,4,8,8-tetrakis[3,5-di(propan-2-yl)phenyl]-2,2-dimethyl-6-phenyl-3a,8a-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
Standard CAS: 1422371-27-4
Multi CAS: No
Basic Information
copy
CAS
1422371-27-4 copy
Multi CAS
No copy
Molecular Formula
C61H81O4P copy
Molecular Weight
909.300000 copy
Exact Mass
908.587248 copy
SMILES
CC(C)C1=CC(=CC(=C1)C2([C@@H]3[C@@H](C(OP(O2)C4=CC=CC=C4)(C5=CC(=CC(=C5)C(C)C)C(C)C)C6=CC(=CC(=C6)C(C)C)C(C)C)OC(O3)(C)C)C7=CC(=CC(=C7)C(C)C)C(C)C)C(C)C copy
InChI
InChI=1S/C61H81O4P/c1-36(2)44-24-45(37(3)4)29-52(28-44)60(53-30-46(38(5)6)25-47(31-53)39(7)8)57-58(63-59(17,18)62-57)61(65-66(64-60)56-22-20-19-21-23-56,54-32-48(40(9)10)26-49(33-54)41(11)12)55-34-50(42(13)14)27-51(35-55)43(15)16/h19-43,57-58H,1-18H3/t57-,58-/m0/s1 copy
InChIKey
AYBKPJJNIOLFCE-YQOHNZFASA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
66 copy
Aromatic heavy atom count
30 copy
Fraction Csp3
0.51 copy
Rotatable bonds
13 copy
H-bond acceptors
4 copy
Molar refractivity
279.03 copy
TPSA
36.92 copy
LogP / Solubility
WLOGP
17.07 copy
MLOGP
15.1 copy
XLogP3
16.7 copy
Consensus LogP
16.29 copy
Log S (ESOL)
-15.71 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-19.34 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-21.29 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
3.85 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
7 copy